Elona Baum
Directeur/Membre du Conseil chez BioEclipse Therapeutics, Inc.
Profil
Elona Baum is currently a Director at Abilitech Medical, Inc., BioEclipse Therapeutics, Inc., and Aegle Therapeutics Corp.
She was also a Director at Endogena Therapeutics, Inc. in the past.
Prior to her current positions, she was the Managing Director at DEFTA Corp.
from 2015 to 2022.
Baum received her undergraduate degree from the University of California, Los Angeles and her doctorate degree from the University of San Francisco School of Law in 1989.
Postes actifs de Elona Baum
| Sociétés | Poste | Début |
|---|---|---|
BioEclipse Therapeutics, Inc.
 BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 24/06/2019 |
Abilitech Medical, Inc.
 Abilitech Medical, Inc. Medical/Nursing ServicesHealth Services Abilitech Medical, Inc. provides solution to restore function and independence to those affected by neuromuscular conditions. Its product portfolio include Abilitech Assist, Abilitech Medical AbiliGrip, and AbiliGrasp Robotic Assist. The company was founded by Angie Zavoral Conley in 2016 and is headquartered in Eden Prairie, MN. | Directeur/Membre du Conseil | - |
Aegle Therapeutics Corp.
 Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Directeur/Membre du Conseil | - |
Endogena Therapeutics, Inc.
 Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 01/01/2014 |
Anciens postes connus de Elona Baum
| Sociétés | Poste | Fin |
|---|---|---|
DEFTA Corp.
 DEFTA Corp. Investment ManagersFinance DEFTA Corp (DEFTA Partners) is a venture capital firm founded in 1984 by George Hara. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/12/2022 |
Formation de Elona Baum
| University of California, Los Angeles | Undergraduate Degree |
| University of San Francisco School of Law | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |
Abilitech Medical, Inc.
Abilitech Medical, Inc. Medical/Nursing ServicesHealth Services Abilitech Medical, Inc. provides solution to restore function and independence to those affected by neuromuscular conditions. Its product portfolio include Abilitech Assist, Abilitech Medical AbiliGrip, and AbiliGrasp Robotic Assist. The company was founded by Angie Zavoral Conley in 2016 and is headquartered in Eden Prairie, MN. | Health Services |
Aegle Therapeutics Corp.
Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Health Technology |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | Health Technology |
DEFTA Corp.
DEFTA Corp. Investment ManagersFinance DEFTA Corp (DEFTA Partners) is a venture capital firm founded in 1984 by George Hara. The firm is headquartered in San Francisco, California. | Finance |
